Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
Ira W. Deveson(Garvan Institute of Medical Research), Binsheng Gong(National Center for Toxicological Research), Kevin Lai(Integrated DNA Technologies (United States)), Jennifer S. LoCoco(Illumina (United States)), Todd Richmond, Jeoffrey Schageman(Thermo Fisher Scientific (United States)), Zhihong Zhang(Burning Rock Biotech (China)), Natalia Novoradovskaya(Agilent Technologies (United States)), James C. Willey(University of Toledo), Wendell Jones(Q2 Solutions (United States)), Rebecca Kusko(Immuneering (United States)), Guangchun Chen(The University of Texas Southwestern Medical Center), Bindu Swapna Madala(Garvan Institute of Medical Research), James Blackburn(Garvan Institute of Medical Research), Igor Stevanovski(Garvan Institute of Medical Research), Ambica Bhandari, Devin Close(ARUP Laboratories (United States)), Jeffrey Conroy, Michael Hubank(Royal Marsden NHS Foundation Trust), Narasimha Marella(Cancer Genetics (United States)), Piotr A. Mieczkowski(University of North Carolina at Chapel Hill), Fujun Qiu(Burning Rock Biotech (China)), Robert Sebra(Icahn School of Medicine at Mount Sinai), Daniel Stetson, Lihyun Sun(NGM Biopharmaceuticals (United States)), Philippe Szankasi(ARUP Laboratories (United States)), Haowen Tan, Lin-ya Tang, Hanane Arib(Icahn School of Medicine at Mount Sinai), Hunter Best(University of Utah), Blake Burgher, Pierre R. Bushel(National Institute of Environmental Health Sciences), Fergal Casey, Simon Cawley(Thermo Fisher Scientific (United States)), Chia-Jung Chang(Stanford University), Jonathan Choi, Jorge M. Dinis, Daniel Duncan(Cancer Genetics (United States)), Agda Karina Eterovic, Liang Feng, Abhisek Ghosal, Kristina Giorda(Integrated DNA Technologies (United States)), Sean T. Glenn, Scott Happe(Agilent Technologies (United States)), Nathan Haseley(Illumina (United States)), Kyle Horvath, Li-Yuan Hung(Harvard University), Mirna Jarosz(Integrated DNA Technologies (United States)), Garima Kushwaha, Dan Li(National Center for Toxicological Research), Quan‐Zhen Li(The University of Texas Southwestern Medical Center), Zhiguang Li(National Institutes of Health), Liang-Chun Liu(Thermo Fisher Scientific (United States)), Zhichao Liu(National Center for Toxicological Research), Marie‐Aline Charles(Cancer Genetics (United States)), Christopher E. Mason(Cornell University), Dalila B. Megherbi(University of Massachusetts Lowell), Tom Morrison, Carlos Pabón-Peña(Agilent Technologies (United States)), Mehdi Pirooznia(National Institutes of Health), Paula Proszek(Royal Marsden NHS Foundation Trust), Amelia Raymond, Paul M. Rindler(ARUP Laboratories (United States)), Rebecca Ringler, Andreas Scherer(University of Helsinki), Rita Shaknovich(Cancer Genetics (United States)), Tieliu Shi(East China Normal University), Melissa Smith(Icahn School of Medicine at Mount Sinai), Ping Song, Maya Strahl(Icahn School of Medicine at Mount Sinai), Venkat J. Thodima(Cancer Genetics (United States)), Nikola Tom(Central European Institute of Technology), Suman Verma, Jiashi Wang(Integrated DNA Technologies (United States)), Leihong Wu(National Center for Toxicological Research), Wenzhong Xiao(Harvard University), Chang Xu(Courtagen Life Sciences (United States)), Mary Qu Yang(University of Arkansas at Little Rock), Guangliang Zhang(Burning Rock Biotech (China)), Sa Zhang(Burning Rock Biotech (China)), Yilin Zhang(NGM Biopharmaceuticals (United States)), Leming Shi(Fudan University), Weida Tong(National Center for Toxicological Research), Donald J. Johann(Winthrop Rockefeller Foundation), Tim R. Mercer(Garvan Institute of Medical Research), Joshua Xu(National Center for Toxicological Research), SEQC2 Oncopanel Sequencing Working Group
Cited by 260Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis